Introduction
Prenatal growth is a dynamic process determined by the interaction of exogenous (including nutrition, infection, and toxicity) and endogenous (genetics) factors, all of which affect cellular proliferation and differentiation and consequently the formation of tissues and organs. These processes occur more rapidly in utero than during any other period of ontogeny, making this stage of development one of the most vulnerable to injury ( Godfrey and Barker, 1995 ; Schneider et al. , 1999 ; Kuzawa and Quinn, 2009 ) . Environmental conditions experienced early in life can profoundly in uence the biology and long-term health of an organism ( Kuzawa, 2007 ) .
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consequence of de ciencies in maternal nutrition, reductions in utero placental blood  ow, and/or malfunctioning of the placenta ( Cross et al. , 1994 ; Godfrey et al. , 1996 ) .
Two main patterns of f o etal growth restriction are observed. When f o etal growth is impaired during the  rst or second trimester, the infant will have symmetric growth restriction. This proportional lack of growth is caused by reduced f o etal cellular proliferation of all organs. In contrast, asymmetric growth, in which an infant has smaller abdominal size compared to head size, will occur if the decrease in growth velocity happens in the last trimester. This head-sparing phenomenon is the most common form of IUGR and is attributed to the ability of the f o etus to adapt, redistributing its cardiac output to the spleen, adrenal, coronary, and cerebral circulations. Although some overlap can occur, the timing of growth delay is more important than aetiology in determining the pattern of growth restriction ( Lin et al. , 1991 ; Brodsky and Christou, 2004 ) . 
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In addition to being a major factor in stillbirth, IUGR has serious consequences for babies who survive. IUGR is associated with increased risk of premature birth , increased morbidity and mortality among premature neonates , hypoxic brain injury and its long-term sequelae, and the need for respiratory support and chronic lung disease ( Garite et al. , 2004 ) . In later life, growth-restricted infants are at increased risk of various disorders, including obesity, diabetes , and ischaemic heart disease ( Cox and Marton, 2009 ) .
Dentists and orthodontists who treat growth-retarded patients must realize that most of these children have a delay in dentofacial development and in dental maturation and that the facial proportions can be thoroughly different from those of normal patients ( van Erum et al. , 1997 ) . Studies of craniofacial growth in children with reduced somatic growth because of different origin have shown that several facial structures are smaller, as could be expected. However, growth retardation does not affect all structures to the same extent, which results in an abnormal facial morphology ( Kjellberg et al. , 2000 ) .
Catch-up growth may be de ned as growth velocity above the statistical limits of normality for age and/or maturity during a de ned period of time following a transient period of growth inhibition. The effect of catch-up growth is to bring a child towards , or in favourable circumstances, right up to its otherwise normal developmental curve ( Williams et al. , 1974 ; Williams, 1981 ) . The use of growth hormone ( GH ) in IUGR, as evidenced in experimental models, results in catch-up growth observed in total body weight ( Guimarey et al. , 2003 ) . In growing children, although GH supplementation to augment their stature has become relatively common, the effects of this practice on the growth of the craniofacial complex are not well understood ( Singleton et al. , 2006 ; Glen et al. , 2008 ) . It is known that in the craniofacial complex, this hormone regulates cartilage formation and accelerates craniofacial growth in children ( van Erum et al. , 1997 ) . On the other hand, Rice et al. (1997) , in an experimental study, using mice treated and untreated with human GH , reported the existence of catch-up growth of skull after the time when normal and dwarf mice, do not usually show any substantial growth. These authors also reported that catch-up growth is an example of both re-stimulated and prolonged growth beyond the time when normal growth has stopped. In this case, the treatment was particularly effective on nasal, maxillary , and mandibular lengths, elements due largely to endochondral ossi cation. However, the effect of the GH on the size of skull bones and how this action affects their relationships have not been studied.
Because human studies can be limited by small sample sizes, cross-sectional designs, uncontrolled variables, and often retrospective nature, animal models have been used to obtain more rigorous analyses ( Nathanielsz, 2006 ; Singleton et al. , 2006 ) . In this sense, during the last decades, IUGR has been studied through experimental models. Many of these models used ligation of uterine vessels in gestating rats as a means to produce the retarded state and are relevant for questions related to human gestation ( Wigglesworth, 1964 ; Ogata et al. , 1985 ; Oyhenart et al. , 1998 ; Huizinga et al. , 2004 , Vuguin, 2007 .
This study presents a longitudinal analysis of morphological changes occurred in the skull of pups from mother rats with reduced blood  ow during gestation, utilizing a functional craniofacial model. The skull is a highly complex integrated region of the skeleton that contains diverse organs and carries out numerous dynamic functions, some of which involve mechanical forces that affect multiple regions. It comprises different components that perform speci c functions -vision, audition, olfaction, breathing, mastication, and neural integration ( Moss and Young, 1960 ; Moss, 1973 ) . Such functions are maintained through the shape and size changes brought about during ontogenetic development ( Moss and Young, 1960 ; Moss, 1997 ; Hallgrímsson et al. , 2007 ) .
Particularly, we evaluated the following hypotheses: 1. if a reduction of blood  ow determines growth retardation, it will have effects on the two major functional components and 2. if the growth retardation continues during the post lactation period, the GH treatment will promote catch-up growth.
Materials and m ethods
Wistar rats ( Rattus norvegicus albinus ), raised at the Instituto de Genética Veterinaria (IGEVET, Facultad de Ciencias Veterinarias, CCT La Plata-CONICET ), were maintained as an outbred colony. The animals were kept free of pathogens and treated in compliance with standardized institutional guidelines. They were housed in solid stainless steel cages at a room temperature ranging from 21 to 25°C and a 12:12 h our photoperiod (lights on at 06:00 a.m.). The animals were fed on a pelleted and sterilized commercial stock diet containing proteins (23 per cent ), carbohydrates (44 per cent ), lipids (11 per cent ), water (8 per cent ),  bre (5 per cent ), ash (5 per cent ), minerals (3 per cent ), and a vitamin mix (1 per cent ). When the rats reached adulthood (70 days), they were mated overnight. Beginning of pregnancy was determined by presence of spermatozoa in vaginal smears. Pregnant rats were housed in individual steel cages, fed on a stock diet ad libitum , and assigned to one of three experimental groups: control (C), i ntrauterine growth retarded (IUGR), and sham -operated (SH). Control dams did not receive any treatment. A lower midline laparotomy under ether anaesthesia was done on the pregnant females of the IUGR group at day 14 of gestation. The arteries near the lower end of each uterine horn were partially ligated with a 3-0 -silk suture ( Oyhenart et al. , 1998 ) . Pregnancy was allowed to proceed until delivery. The SH dams were subjected to laparotomy, but without vessel bending, in order to isolate the effects of surgery from those of vessel ligation. 
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After delivery, IUGR (37 males and 31 females) and SH (15 males and 15 females) pups were cross -fostered to well nourished control dams. Control pups (16 males and 15 females) continued lactation with their own mothers. A standard diet was available ad libitum to the mothers. The IUGR group was divided into two subgroups: non-treated IUGR (14 males and 14 females) and IUGR + GH (23 males and 17 females) , which were injected subcutaneously with GH (3.0 mg/kg/day of Genotropin®) between 21 and 60 days old. SH pups were injected with only the hormonal vehicle with the same doses and periodicity as those for the IUGR + GH group.
After weaning, all the animals were fed a stock diet ad libitum . This experimental protocol was approved by the UNLP ethics committee for animal research.
Measurements
Males and females of each group were X-rayed under light ether anaesthesia at 1, 21, 42, 63, and 84 days of age in order to obtain the longitudinal data for each animal. After sedation, the rats were oriented in a cephalostat and radiographed in dorso ventral and lateral planes with a Siemens Heliophos 4 at 240 mA/125 kV. Shoots were regulated at 100 mA, 0.02 seg, 40 -50 kW (according to the age of the animal). AGFA Mamoray MR5-II, 18 × 24 cm  lm was used for the radiographs. A 110 cm focus - lm distance was used to reduce the magni cation effect, calculated as MgC = Bx/Ax, where MgC is the magni cation coef cient, Ax a variable measured on the 84th day radiograph, and Bx the same variable measured on the skull ( Pucciarelli et al. , 2001 ). The length, width, and height of major neurocranial (NL, NW, and NH) and facial (FL, FW, and FH) components were measured on each radiograph with a Fowler Max-Cal Digitrix caliper (0.01 mm accuracy ; Figure 1 ). All measurements were made by one author (F.A.Q.), which precluded interobserver differences. Intraobserver repeatability was assessed by remeasuring 20 randomly selected cases per age (15 per cent of the total sample). Intraobserver error was calculated using the Dahlberg statistic: √ ( ∑ d 2 /2 n ), where d 2 is the quadratic difference between pairs of repeated measurements and n the number of pairs of measurements. This statistic is expressed in millimetres and can be interpreted as the average disparity between measurement sessions. Intraobserver error was less than 0.1 mm for all variables.
To estimate the size variations of the major components with respect to age and gender , volumetric indices were calculated as follows: neurocranial index (VNI) = 3 √ NL × NW × NH; facial index (VFI)= 3 √ FL × FW × FH ( Cesani et al. , 2006 ) .
Statistical a nalysis
The data corresponding to neurocranial and facial lengths, widths, and heights were processed statistically by analysis of variance (ANOVA) and the values for  nal age (day 84) by principal components analysis (PCA). In order to avoid the full-size differences between males and females and according to the patterns of sexual dimorphism exhibited by this species ( Hughes and Tanner, 1970 ; Jansson et al. , 1983 ; Rol De Lama et al. , 2001 ) , data for each gender were analysed through separate PCAs. 
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The volumetric indices were analysed by non -linear regression curves, adjusted to: y = e a + b /x . The parameter a estimated in this model was the value for maximum growth, while the reciprocal of age represented the growth rate; with e a being the size of the  nal neurocranial component, b the growth rate, and e the base in Napierian logarithms. Differences in the neurocranial and facial volumetric indices among the groups studied, with the control group as reference, were calculated based on the estimations made in this model.
Results
The ANOVA on postnatal day 1 showed highly signi cant differences in neurocranial length, width , and height and facial width between treatments ( Table 1 ) . The post hoc analysis revealed signi cant differences in neurocranial length between C and SH of both genders ( Table 2 ) . Consequently, the SH animals were chosen as the reference group. Moreover, IUGR males and females evinced signi cant growth retardation in both neurocranial (length and height) and facial (length and width) components; in addition, females exhibited signi cant differences in neurocranial width ( Table 2 ) . Table 3 presents the mean and standard deviation of neurocranial and facial volume from day 1 through 84. Table 4 summarizes the results from non -linear regression analysis of neurocranial and facial volumes. In both genders ,  nal neurocranial volume did not exhibit signi cant differences between the animals of the SH and IUGR + GH groups, with the IUGR group having a lower value. On the other hand, there was no difference in the growth rates of the neurocranium between SH and IUGR animals. In contrast, IUGR + GH showed signi cant slower growth than the SH group. Final facial volume did not exhibit signi cant differences among the three groups; however, growth rates were different because the SH group presented higher values than the IUGR and IUGR + GH rats. Figure 2 shows the differences between the means of neurocranial and facial volumetric indices, estimated by the regression model, for the pairs SH -IUGR and SH -IUGR + GH.
In males, the  rst PCA axis accounted for 50.0 per cent of the total variance with an eigenvalue of 1.19, and all variables correlated positively with this axis (with the exception of facial length), thus re ecting a strong effect of size on separating the different treatment groups (SH = IUGR + GH > IUGR). The second axis summarized 24.8 per cent of the remaining variance with an eigenvalue of 0.59, thus indicating shape variation ( Table 5 , Figure 3 ) .
In females, the  rst PCA axis accumulated 47.8 per cent of the total variance with an eigenvalue of 1.03, separating the treatment groups (SH = IUGR + GH > IUGR) and showing positive correlation with all the variables, i.e. effect of size. The second axis captured 30.6 per cent of the remaining variance with an eigenvalue of 0.66, expressing shape variation ( Table 5 , Figure 4 ) . 
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Discussion
Functional cranial components can be differentially altered by environmental factors. As a result, the facial component appears to be more susceptible than the neurocranial one ( Pucciarelli, 1981 ; Fields, 1991 ) . Accordingly, previous reports have indicated that IUGR rats, whose mothers had their uterine vessels ligated at the beginning of gestation, showed more signi cant facial than neurocranial growth retardation ( Oyhenart et al. , 1998 ) . In this case, the ligation was made during the last third of gestation, and growth retardation affected both these major components. Thus, this discrepancy might have arisen as a consequence of differences in timing of the prenatal stress period. R 2 (R squared) = coef cient of determination; F = F-statistic -goodness of  t. * P > 0.01, ** P > 0.001, *** P > 0.000. 6 of 9
According to Woodall et al. (1996) and Oyhenart et al. (2002) , neurofacial proportions evidence a strong effect of IUGR. Our results agree with earlier  ndings reported by Quintero et al. (2005) in which intrauterine growthretarded rats showed signi cant cranial allometric effects. Because the skull size of IUGR animals does not reach normal values, it is assumed that it does not recover by itself. The lack of growth recovery in IUGR has been associated with multiple causes, including growth rate during the very  rst months of life ( Karlberg and Albertsson-Wikland, 1995 ) , individual variability, nutritional circumstances ( Stanley and Speidel, 1985 ) , and endocrine dysfunctions such as insuf cient secretion of GH or low somatomedin activity ( Hokken-Koelega et al. , 1995 ) . 
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like the facial component, showed a decrease in growth rate. These  ndings indicated that both the neurocranial and the facial functional components displayed different potential for growth recovery, probably linked to GH therapy. It has been suggested that depending on the timing of GH supplementation, there is potential for change in proportions or shape of the craniofacial complex ( Singleton et al. , 2006 ) . In this sense, Vandeberg et al. (2004) reported that the relative maturity of different segments was able to limit skull growth. Consequently, different craniofacial morphologies may result depending on the timing of GH supplementation therapy. Also, Glen et al . (2008) , in an experimental model of early GH supplementation on growth of the craniofacial complex, demonstrated that GH normal animals respond differently to GH supplementation than animals with a GH de ciency. Although the prenatal development of vertebrates consists of a highly ordered process, it can become fragmented into relatively dissociated processes. This fragmentation, know as modularity, allows independent adaptation of different functions in the absence of interference with each other ( Bonner, 1988 ; Raff, 1996 ; Polly et al. , 2001 ) . In this way, each functional module can be modi ed differentially by environmental in uences and exhibits an individual potential for recovery.
Several authors have proposed that the neurocranium, the facial skull, and the cranial base behave as separate modules, showing variation with a certain degree of independence ( Lieberman et al. , 2000 ; Hallgrímsson et al. , 2004 ) . Both the allometric effect observed in the skull of IUGR rats and the differing responses of the two major components in relation to the application of GH could be regarded as the result of a complex adaptive process. Each module shows a different developmental phenotypic reaction to early intrauterine injury and GH treatment. The effect of GH is also known to be different in different regions of the skull ( Ramirez Yañez et al. , 2005 ) . Accordingly, it is proposed that the phenotypic plasticity of prenatal development allows mammals to delay or accelerate development depending on environmental conditions ( Amiel Tison et al. , 2004 ) . Postnatal development exhibits greater capacity than in utero development for varying over time. Nevertheless, changes in utero are very important since the adverse intrauterine environment results in prenatal re programming due to epigenetic mechanisms ( Krause et al. , 2009 ; Vehaskari, 2010 ) . This capacity to modulate development in response to the environment is considered an early acquisition in evolutionary terms ( Amiel Tison et al. , 2004 ) .
We conclude that a reduction of placental blood  ow in rats modi es the cranial growth and its functional neurocranial and facial components. The skull of IUGR animals exhibits modular behaviour with different recovery strategies. Neurocranial growth exhibits a catch-up response only through the action of GH, changing the timing of growth. Analysis of the pattern of cranial dimensions in this experiment revealed the occurrence of differential catch-up in the volumes of the two functional components. The volume of the facial component was recovered in both IUGR and IUGR + GH groups. However, they both showed a decrease in the growth rate and a change in the timing of growth. The volume of the neurocranial component, however, was only regained after GH supplementation, but F. A. QUINTERO ET AL.
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Facial growth, in contrast, displays a catch-up development in IUGR animals, treated and untreated with GH, changing the growth rate. Furthermore, these results are relevant for pediatrics, orthodontics, and biological anthropology among other areas, in relation to the regulatory mechanisms of craniofacial growth and growth-retarded children treated with GH.
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